← Back to recalls

MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))

Class II
Recalling firm
Nipro Renal Soultions USA, Corporation
Reason for recall
Hemodialysis concentrates contain high endotoxin levels
Affected products (lot / model / serial)
DB+201-2.1: Lot -NDB5E004(exp.4/30/2027) DB+201-25: Lots - NDB5M011(Exp.12/05/2027, NDB4J003(exp.9/25/2026)
Units affected
2,327 cases
Distribution pattern
Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.
Firm location
Lewisberry, PA, United States
Recall type
Voluntary: Firm initiated
How the firm notified customers
Letter
Product type
Devices
Status
Ongoing
Recall number
Z-3134-2026
Recall initiated
August 5, 2026
FDA classification date
September 10, 2026
FDA report date
September 16, 2026
FDA event ID
99573
Last updated on HTM Vibe
September 23, 2026
View on openFDA